Symrise Acquires Kaden Biochemicals

Symrise (Holzminden, Germany) has acquired Kaden Biochemicals GmbH, a company that develops and produces high purity active ingredients from plant material.

Of the acquisition, Symrise CEO Gerold Linzbach said, “This acquisition gives us a good position on the highly attractive market for functional food and nutraceuticals. As a result, we can now offer a much broader spectrum, and we can present ourselves even more strongly as a source of comprehensive sensory solutions for nearly every challenge on the market.”

More in Companies